114 related articles for article (PubMed ID: 7173306)
1. Serum concentration and protein binding of thioridazine and its metabolites in patients with chronic alcoholism.
Axelsson R; Mårtensson E; Alling C
Eur J Clin Pharmacol; 1982 Oct; 23(4):359-63. PubMed ID: 7173306
[TBL] [Abstract][Full Text] [Related]
2. Plasma levels of thioridazine and metabolites are influenced by the debrisoquin hydroxylation phenotype.
von Bahr C; Movin G; Nordin C; Lidén A; Hammarlund-Udenaes M; Hedberg A; Ring H; Sjöqvist F
Clin Pharmacol Ther; 1991 Mar; 49(3):234-40. PubMed ID: 2007317
[TBL] [Abstract][Full Text] [Related]
3. Binding of thioridazine and thioridazine metabolites to serum proteins. An in vitro study.
Nyberg G; Mårtensson E
Naunyn Schmiedebergs Arch Pharmacol; 1982 Jun; 319(3):189-96. PubMed ID: 7110380
[TBL] [Abstract][Full Text] [Related]
4. Unbound plasma concentrations, total plasma concentrations, and red blood cell concentrations of thioridazine and its main metabolites: an in vitro study.
Nyberg G; Mårtensson E
Naunyn Schmiedebergs Arch Pharmacol; 1987 Apr; 335(4):465-8. PubMed ID: 3600822
[TBL] [Abstract][Full Text] [Related]
5. Sulphoxide metabolites of thioridazine in man.
Papadopoulos AS; Crammer JL
Xenobiotica; 1986 Dec; 16(12):1097-107. PubMed ID: 3798957
[TBL] [Abstract][Full Text] [Related]
6. Thioridazine and its metabolites in post mortem blood, including two stereoisomeric ring sulfoxides.
Poklis A; Wells CE; Juenge EC
J Anal Toxicol; 1982; 6(5):250-2. PubMed ID: 7176556
[TBL] [Abstract][Full Text] [Related]
7. Concentrations of thioridazine and thioridazine metabolites in erythrocytes.
Svensson C; Nyberg G; Axelsson R; Mårtensson E
Psychopharmacology (Berl); 1986; 89(3):291-2. PubMed ID: 3088651
[TBL] [Abstract][Full Text] [Related]
8. Metabolism of piperidine-type phenothiazine antipsychotic agents. IV. Thioridazine in dog, man and rat.
Lin G; Hawes EM; McKay G; Korchinski ED; Midha KK
Xenobiotica; 1993 Oct; 23(10):1059-74. PubMed ID: 8259689
[TBL] [Abstract][Full Text] [Related]
9. Binding of thioridazine and thioridazine metabolites to serum proteins in psychiatric patients.
Nyberg G; Axelsson R; Mårtensson E
Eur J Clin Pharmacol; 1978 Dec; 14(5):341-50. PubMed ID: 32045
[No Abstract] [Full Text] [Related]
10. Plasma concentrations of thioridazine metabolites and ECG abnormalities.
Gottschalk LA; Dinovo E; Biener R; Nandi BR
J Pharm Sci; 1978 Feb; 67(2):155-7. PubMed ID: 621628
[TBL] [Abstract][Full Text] [Related]
11. Total plasma concentrations, red blood cell concentrations, and radioreceptor assay values compared with unbound plasma concentrations of thioridazine and thioridazine metabolites in psychiatric patients.
Nyberg G; Svensson C; Olofsson U; Axelsson R; Mårtensson E
Ther Drug Monit; 1987 Dec; 9(4):426-32. PubMed ID: 3424408
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of thioridazine and its metabolites in blood plasma and the brain of rats after acute and chronic treatment.
Daniel WA; Syrek M; Mach A; Wójcikowski J; Boksa J
Pol J Pharmacol; 1997; 49(6):439-52. PubMed ID: 9566048
[TBL] [Abstract][Full Text] [Related]
13. Binding of thioridazine and some of its metabolites to human serum protein and human albumin.
Belpaire FM; Vanderheeren FA; Bogaert MG
Arzneimittelforschung; 1975; 25(12):1969-71. PubMed ID: 1243669
[TBL] [Abstract][Full Text] [Related]
14. Plasma levels and half lives of thioridazine and some of its metabolites. I. High doses in young acute schizophrenics.
Vanderheeren FA; Muusze RG
Eur J Clin Pharmacol; 1977 Jan; 11(2):135-40. PubMed ID: 320014
[TBL] [Abstract][Full Text] [Related]
15. Plasma levels and half lives of thioridazine and some of its metabolites. II. Low doses in older psychiatric patients.
Muusze RG; Vanderheeren FA
Eur J Clin Pharmacol; 1977 Jan; 11(2):141-7. PubMed ID: 837967
[TBL] [Abstract][Full Text] [Related]
16. Measurement of thioridazine in blood and urine.
Ng CH; Crammer JL
Br J Clin Pharmacol; 1977 Apr; 4(2):173-83. PubMed ID: 16633
[TBL] [Abstract][Full Text] [Related]
17. A pilot of plasma thioridazine and metabolites in chronically treated patients.
Papadopoulos AS; Chand TG; Crammer JL; Lader S
Br J Psychiatry; 1980 Jun; 136():591-6. PubMed ID: 7388266
[TBL] [Abstract][Full Text] [Related]
18. The biotransformation of thioridazine to thioridazine 5-sulfoxide stereoisomers in phenobarbital induced rats.
Hale PW; Poklis A
Eur J Drug Metab Pharmacokinet; 1986; 11(4):283-9. PubMed ID: 3582423
[TBL] [Abstract][Full Text] [Related]
19. Identification of a metabolite of thioridazine and mesoridazine from human plasma.
Gruenke LD; Craig JC
Res Commun Chem Pathol Pharmacol; 1975 Feb; 10(2):221-5. PubMed ID: 1162173
[TBL] [Abstract][Full Text] [Related]
20. Serum concentrations of thioridazine, its major metabolites and serum neuroleptic-like activities in schizophrenics with and without tardive dyskinesia.
Widerlöv E; Häggström JE; Kilts CD; Andersson U; Breese GR; Mailman RB
Acta Psychiatr Scand; 1982 Oct; 66(4):294-305. PubMed ID: 7148482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
